Cargando…

Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy

Detalles Bibliográficos
Autores principales: Crombie, Jennifer L., Jacobson, Caron A., Redd, Robert, Shouse, Geoffrey, Herrera, Alex F., Chow, Victor A., Gauthier, Jordan, Mullane, Erin, Cahill, Kirk, Kline, Justin, Romancik, Jason, Cohen, Jonathon B., Saucier, Anna, Houot, Roch, Armand, Philippe, Hess, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690912/
https://www.ncbi.nlm.nih.gov/pubmed/37259597
http://dx.doi.org/10.3324/haematol.2022.282345
_version_ 1785152623487221760
author Crombie, Jennifer L.
Jacobson, Caron A.
Redd, Robert
Shouse, Geoffrey
Herrera, Alex F.
Chow, Victor A.
Gauthier, Jordan
Mullane, Erin
Cahill, Kirk
Kline, Justin
Romancik, Jason
Cohen, Jonathon B.
Saucier, Anna
Houot, Roch
Armand, Philippe
Hess, Brian
author_facet Crombie, Jennifer L.
Jacobson, Caron A.
Redd, Robert
Shouse, Geoffrey
Herrera, Alex F.
Chow, Victor A.
Gauthier, Jordan
Mullane, Erin
Cahill, Kirk
Kline, Justin
Romancik, Jason
Cohen, Jonathon B.
Saucier, Anna
Houot, Roch
Armand, Philippe
Hess, Brian
author_sort Crombie, Jennifer L.
collection PubMed
description
format Online
Article
Text
id pubmed-10690912
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-106909122023-12-02 Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy Crombie, Jennifer L. Jacobson, Caron A. Redd, Robert Shouse, Geoffrey Herrera, Alex F. Chow, Victor A. Gauthier, Jordan Mullane, Erin Cahill, Kirk Kline, Justin Romancik, Jason Cohen, Jonathon B. Saucier, Anna Houot, Roch Armand, Philippe Hess, Brian Haematologica Letter to the Editor Fondazione Ferrata Storti 2023-06-01 /pmc/articles/PMC10690912/ /pubmed/37259597 http://dx.doi.org/10.3324/haematol.2022.282345 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letter to the Editor
Crombie, Jennifer L.
Jacobson, Caron A.
Redd, Robert
Shouse, Geoffrey
Herrera, Alex F.
Chow, Victor A.
Gauthier, Jordan
Mullane, Erin
Cahill, Kirk
Kline, Justin
Romancik, Jason
Cohen, Jonathon B.
Saucier, Anna
Houot, Roch
Armand, Philippe
Hess, Brian
Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy
title Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy
title_full Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy
title_fullStr Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy
title_full_unstemmed Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy
title_short Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy
title_sort prognostic value of early positron emission tomography in patients with large b-cell lymphoma treated with anti-cd19 chimeric antigen receptor t-cell therapy
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690912/
https://www.ncbi.nlm.nih.gov/pubmed/37259597
http://dx.doi.org/10.3324/haematol.2022.282345
work_keys_str_mv AT crombiejenniferl prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy
AT jacobsoncarona prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy
AT reddrobert prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy
AT shousegeoffrey prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy
AT herreraalexf prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy
AT chowvictora prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy
AT gauthierjordan prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy
AT mullaneerin prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy
AT cahillkirk prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy
AT klinejustin prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy
AT romancikjason prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy
AT cohenjonathonb prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy
AT saucieranna prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy
AT houotroch prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy
AT armandphilippe prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy
AT hessbrian prognosticvalueofearlypositronemissiontomographyinpatientswithlargebcelllymphomatreatedwithanticd19chimericantigenreceptortcelltherapy